BOSCARO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 10.089
EU - Europa 4.992
AS - Asia 3.713
SA - Sud America 830
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 96
OC - Oceania 7
Totale 19.865
Nazione #
US - Stati Uniti d'America 9.925
RU - Federazione Russa 1.351
SG - Singapore 1.285
UA - Ucraina 829
VN - Vietnam 780
BR - Brasile 659
CN - Cina 484
DE - Germania 438
IT - Italia 410
IE - Irlanda 401
SE - Svezia 363
TR - Turchia 326
DK - Danimarca 317
FR - Francia 272
HK - Hong Kong 265
FI - Finlandia 230
GB - Regno Unito 200
KR - Corea 171
IN - India 86
BD - Bangladesh 71
CA - Canada 67
MX - Messico 50
NL - Olanda 49
AR - Argentina 47
CI - Costa d'Avorio 47
ZA - Sudafrica 38
EC - Ecuador 34
IQ - Iraq 34
BE - Belgio 32
JP - Giappone 27
CO - Colombia 26
ID - Indonesia 25
PL - Polonia 25
PK - Pakistan 24
UZ - Uzbekistan 22
VE - Venezuela 22
ES - Italia 17
LT - Lituania 14
MA - Marocco 14
PH - Filippine 13
CL - Cile 12
PY - Paraguay 12
RO - Romania 10
HN - Honduras 9
KE - Kenya 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
TH - Thailandia 8
AZ - Azerbaigian 7
JM - Giamaica 7
JO - Giordania 7
MY - Malesia 7
PE - Perù 7
AT - Austria 6
EG - Egitto 6
EU - Europa 6
KZ - Kazakistan 6
NP - Nepal 6
OM - Oman 6
TN - Tunisia 6
TW - Taiwan 6
UY - Uruguay 6
AL - Albania 5
BO - Bolivia 5
CR - Costa Rica 5
GT - Guatemala 5
DZ - Algeria 4
ET - Etiopia 4
IR - Iran 4
TT - Trinidad e Tobago 4
AO - Angola 3
AU - Australia 3
BB - Barbados 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BS - Bahamas 2
CH - Svizzera 2
GA - Gabon 2
GD - Grenada 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
TJ - Tagikistan 2
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
Totale 19.757
Città #
Ashburn 1.398
Chandler 857
Jacksonville 834
Singapore 814
Des Moines 708
San Jose 510
Boardman 448
Fairfield 423
Dublin 400
Council Bluffs 386
New York 295
Dallas 265
Hong Kong 257
Wilmington 253
Ho Chi Minh City 243
Woodbridge 230
Seattle 189
Ann Arbor 179
Princeton 171
Houston 168
Lawrence 168
Hanoi 167
The Dalles 149
Cambridge 146
Lauterbourg 145
San Mateo 137
Moscow 127
Los Angeles 118
Beijing 108
Hefei 102
São Paulo 81
Centro 64
Helsinki 55
San Diego 55
Da Nang 50
Abidjan 47
Santa Clara 46
Buffalo 44
Orem 40
Grand Rapids 38
Munich 35
Turin 33
Brussels 32
Haiphong 30
Washington 27
Frankfurt am Main 26
Milan 26
London 24
Norwalk 24
Rio de Janeiro 24
Tokyo 23
Chicago 22
Rome 21
Warsaw 21
Montreal 20
Brooklyn 19
Johannesburg 19
Mumbai 19
Tashkent 19
Chennai 17
Denver 17
Mexico City 17
Phoenix 17
Guayaquil 16
Atlanta 15
Civitanova Marche 15
Falls Church 15
Stockholm 15
San Francisco 14
Toronto 14
Amsterdam 13
Belo Horizonte 13
Biên Hòa 13
Guangzhou 13
Shanghai 13
Baghdad 12
Hải Dương 12
Manchester 12
Thái Bình 12
Ankara 11
Bắc Ninh 11
Miano 11
Nuremberg 11
Temecula 11
Wuhan 11
Can Tho 10
Curitiba 10
Phủ Lý 10
Turku 10
Cape Town 9
Dhaka 9
Miami 9
Nairobi 9
New Delhi 9
Porto Alegre 9
Quito 9
Quận Ba 9
Thái Nguyên 9
Boston 8
Caracas 8
Totale 11.867
Nome #
ISOLATION AND CHARACTERIZATION OF MESENCHYMAL CELLS FROM PITUITARY TUMOURS 831
Adrenal incidentaloma: surgical update. 199
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 194
Production of peroxynitrite by human spermatozoa and its possible role on sperm motility. 183
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 182
Correlates of perceived health related quality of life in obese, overweight and normal weight older adults: an observational study 180
Persistent psychological distress in patients treated for endocrine disease. 173
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. 172
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 170
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. 166
Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. 164
Prolactinomas,Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas 163
Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. 162
Aldosterone as a cardiovascular risk factor. 158
Adipose tissue 11 beta-hydrioxysteroid deydrogenase type 1 expression in obesity and Cushing's syndrome 158
Age-related changes in glucocorticoid fast feedback inhibition of adrenocorticotropin in man. 157
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. 156
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. 155
A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma. 152
Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists 151
Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers 149
Free thiols in human spermatozoa: involvement of Na/K-ATPase and Ca-ATPase activities in sperm motility. 148
Adipose cell-adrenal interactions: current knowledge and future perspectives. 147
Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. 147
Development of overt Cushing's syndrome in patients with adrenal incidentaloma 144
Bone health and aldosterone excess 144
Adrenal incidentaloma: effects on bone metabolism. 142
Protective effect of leg fat against cardiovascular risk factors in obese premenopausal women 142
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 142
Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse. 141
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. 141
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 141
Genetic mutations in thyroid carcinoma 137
A clinical index for rating severity in Cushing's syndrome 137
Psychosocial impairment in patients treated for pituitary disease: a controlled study 136
Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders. 135
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. 134
Adrenocortical carcinoma:experience in 45 patients. 134
Adrenal incidentaloma. 131
Chemical-physical properties of lipoproteins in anorexia nervosa. 130
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY. 130
Coenzyme Q10 and male infertility 130
Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. 130
Effects of raloxifene on body fat distribution and lipid profile in healthy post menopausal women 129
GH secretagogues and hypothalamo-pituitary-adrenal axis 129
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study. 129
Multiple endocrine neoplasia type 1 and adrenal lesions 128
Anaplastic Thyroid Carcinoma. 128
Development of overt Cushing's syndrome in patients with adrenal incidentaloma. 146 (1): 61-66,2002 126
Coenzyme Q10 supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. 126
Cushing's syndrome 125
Diagnosis and management of adrenal incidentalomas. 125
Brief report: A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma 125
Diagnosis and complications of Cushing's syndrome: a consensus statement 124
Consideration in diagnosis of Cushing's syndrome 124
Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas 124
Obesity and body mass index (BMI) in ralation to the life style and psycho-social aspects. 123
Left ventricular structure and functional characteristic in Cushing's syndrome 123
Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma 123
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 122
Effect of natural early menopause on bone mineral density. 121
5 Management of primary aldosteronism: Its complications and their outcomes after treatment 121
Personality characteristics and quality of life in patients treated for Cushing's syndrome 120
Oleoylethanolamide protects human sperm cells from oxidation stress: studies on cases of idiopathic infertility 120
Cortical adrenal mitochondrial morphology changes in functional state: new insights. 120
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gps mutations . 120
Recovery of Bone Mineral Density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome 118
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis. 117
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 117
Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation. 117
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 117
Sexual symptoms in endocrine diseases: psychosomatic perspectives. 116
Molecolar analysis of CDKN1C and TP53 in sporadic adrenal tumors 116
Obesity and body mass index (BMI) in relation to life-style and psycho-social aspects. 116
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. 116
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease 115
Endocrine aspects of cancer gene therapy. 115
Gene therapy for thyroid cancer. 115
La nutraceutica nell’infertilità maschile. 114
Improvement of sperm cells motility after CoQ10 treatment in infertile males with idiopathic asthenozoospermia. 114
New treatment guidelines on Cushing's disease. 113
Idiopathic infertility: effect of palmitoylethanolamide (a homologue of anandamide) on hyperactivated sperm cell motility and Ca2+ influx. 113
Corticotropin-releasing effect of exarelin, a peptyl GH secretagogue in normal subjects pretreated with metyrapone or RU 486, a glucocorticoid receptor antagonist, and patients with Addison's disease 112
Self image and quality of life in acromegaly 112
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 112
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 111
Foreword. Glucocorticoid-induced osteoporosis. 110
Diagnosis of primary aldosteronism: from screening to subtype differentiation 110
Idiopathic infertility: susceptibility of spermatozoa to in vitro capacitation, in the presence and the absence of Palmitylethanolamide (an homologue of Anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. 110
Chemotherapy at the end of life: an open question. 109
Can the ISO9000 quality assessment be applied to the practice of medical oncology? 109
Morphometric dual-energy X-ray absorptiometry (MXA) for identification of vertebral fractures. 108
Prevalence and natural history of adrenal incidentalomas. 108
GH deficiency in the transitio period: body composition and gonad function. 108
Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations. 108
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. 108
Effect of the serotonin antagonists ritanserin and ketanserin in Cushing disease 107
Inactivation of the p16 tumor suppressor gene in adrenocortical tumors. 107
Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease. 107
Raloxifene and cadiovascular health: its relationschip to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women 106
Totale 13.884
Categoria #
all - tutte 83.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022833 0 0 0 64 19 93 39 74 82 135 83 244
2022/20232.866 202 221 173 211 217 897 0 183 594 10 114 44
2023/20241.387 254 40 72 233 229 303 18 49 0 32 9 148
2024/20252.093 134 207 123 21 86 57 137 78 567 129 218 336
2025/20266.322 364 429 214 583 560 491 1.193 630 1.119 421 134 184
2026/20271.520 243 310 451 516 0 0 0 0 0 0 0 0
Totale 19.865